key: cord-0890561-p6ooxwge
authors: Ünsaler, Selin; Okan, Ayşe; Tekin, Süda; Hafız, Ayşenur M.; Gökler, Ozan; Altuntaş, Ozan
title: Comparison of nasopharyngeal swab and nasopharyngeal aspiration in adults for SARS‐CoV‐2 identification using reverse transcription‐polymerase chain reaction
date: 2021-08-07
journal: J Med Virol
DOI: 10.1002/jmv.27250
sha: 8cda12ccb386323983ab14bdf0f0aea5f0e677cc
doc_id: 890561
cord_uid: p6ooxwge

We aimed to compare reverse transcription‐polymerase chain reaction (RT‐PCR) results of nasopharyngeal aspiration (NA) and nasopharyngeal swab (NS) samples in the diagnosis of coronavirus disease 2019. NS was obtained with a dacron swab and NA was performed by aspiration cannula. The sampling was performed by an otolaryngologist to ensure standardized correct sampling from the nasopharynx. RT‐PCR was performed for the detection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The level of agreement between the result of NA and NS samples for each patient was analyzed. The Ct values were compared. Thirty‐three patients were enrolled in the study with a mean age of 56.3 years. Thirteen subjects resulted negative with both NS and NA; 20 subjects resulted positive with NA and 18 subjects resulted positive with NS. The mean values of Ct for NA samples and NS samples were 24.6 ± 5.9 and 24 ± 6.7, respectively. There was no statistical difference between Ct values of NA and NS samples (p = 0.48). RT‐PCR for SARS‐Cov2 performed with NA sample and NS sample showed a strong correlation regarding the positivity/negativity and the Ct values.

Coronavirus disease 2019 (COVID-19) has become a pandemic in over a year, and the reverse transcription-polymerase chain reaction (RT-PCR) assay remains the most widely used testing method to detect severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). 1,2 However, obtaining a positive test is not always possible, despite the presence of clinical and radiological findings consistent with COVID-19 in hospitalized patients. This has led clinicians to collect different kinds of biological specimens. 3 The tests currently used for the direct identification of SARS-CoV-2 include specimens such as oropharyngeal and nasopharyngeal swab, nasopharyngeal aspirate, and the lower respiratory tract samples. [4] [5] [6] Upper respiratory specimens are easily obtainable and their sampling exposes the patients to less invasive procedures than the lower respiratory specimens. In contrast, collection of the lower respiratory samples necessitates a skilled operator and is also uncomfortable for the patients. Instead, collection of a nasopharyngeal swab and throat swab is simple and safe for routine diagnosis and monitoring of the SARS-CoV-2. 4 A negative test result does not rule out the infection. 7 SARS-CoV-2 testing failure may result from preanalytic errors such as sampling error, deficiencies in transporting of the sample, and potentially limited RNA found in the samples. Testing of specimens from multiple sites may aid in reducing false-negative results. 8 In this study, we aimed to investigate the factor of sampling error caused due to insufficient material sampling. Nasopharyngeal sampling with aspiration provides a greater amount of secretion to be obtained so it is expected to yield more accurate results than the swab. Moving from this idea, we tested the patients with nasopharyngeal aspiration (NA) at the same time as with a nasopharyngeal swab (NS) to compare the viral load in specimens obtained by two techniques and to assess its effect on the test results.

This study was conducted in a single tertiary referral center. It is approved by the Koç University Ethical Committee, and informed consent for nasopharyngeal sampling was obtained from all patients. There were two subjects, who resulted positive with NA but negative with NS. One of these two subjects was tested on the eighth day of symptoms and the other on the 12th day of symptoms. The results showed very good strength of agreement between NA and NS regarding positivity and negativity, as the κ value was 0.87. The mean value of Ct for NA samples was 24.6 ± 5.9 and the mean value of Ct for NS samples was 24 ± 6.7. There was no statistical difference between Ct values of NA and NS samples (p = 0.48), so sampling with nasopharyngeal swab was found to be as efficient as nasopharyngeal aspiration.

It is crucial to diagnose COVID-19 accurately by the correct method of testing to manage treatment, reduce spread of the disease, and protect healthcare professionals. There is as yet no gold standard for the diagnosis of SARS-Cov-2 infection, and RT-PCR remains the most widely used testing method. 9 The nasopharynx, as an accessible site through the nose, is the most widely used sampling site. The testing may result in false negatives because of preanalytic factors such as inadequate sampling or low viral load. The timing of sampling is also known to be an important factor for obtaining a positive result, as the viral load in the nasopharynx is low in the first days of the infection and also decreases after 7 days of symptom onset. 10 In the literature, there are studies that compared the PCR results of lower respiratory tract specimens (laryngotracheal aspirate/sputum) with NS. Nazerian et al. 11 reported a reduced false-negative rate with laryngotracheal specimens in patients with suspected SARS-COV-2 pneumonia despite a negative NPS. In contrast, Thwe et al. 12 reported an overall agreement of 96% between tracheal aspirate/sputum specimens and NS; interestingly, though, five discordant results were positive for NS but negative for sputum. As we aimed to investigate the efficacy of NS and a possible effect of increasing the sample material on test results, we compared the viral load and the test results obtained from NS with that of NA, which is expected to yield more biological material from the sampling site. In the literature, there are similar studies 2 | ÜNSALER ET AL.

for other respiratory viruses, which compares the efficacy of NS and NA, but not yet for SARS-CoV-2 infection in adults. The optimal sampling methods and the best sites to collect material for viral detection for the etiologic diagnosis of respiratory viral infections may differ between different viruses 13 ; for example, sampling with aspiration was reported to increase the sensitivity of PCR for the respiratory syncytial virus when compared to sampling with a swab. 13, 14 In our study, the idea of getting NA was adopted with the intention of obtaining a positive result for subjects who resulted negative with NS but are clinically and radiologically consistent with COVID-19. However, in the study design, no such criteria were de- The participants of the study mentioned that the aspiration process caused no further discomfort than the swab, or even provided higher comfort. This is probably because of the softer and flexible structure of the cannula compared with the swab. It is less likely to obtain an insufficient amount of material with NA than that with NS. Therefore, NA may be preferred for the second sampling, especially in patients who are difficult to be sampled with swab because of a septal deviation or patient incompatibility.

The limitation of the study was the small number of subjects, which was limited on purpose for prevention of aerosolization and patient discomfort due to double sampling at the same time. The sampling was done under optimal conditions, unlike the daily routine practice. It is to be noted that both sampling methods were applied to the same patient by the otolaryngologist. Thus, it was certainly collected with absolute precision. If we consider the fact that the sampling is generally performed by other healthcare professionals, the difference in results between NS and NA would be expected to be higher in less experienced hands.

This study did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

We would like to thank Arzu Baygül from Koç University School of Medicine Department of Biostatistics for skilled statistical support.

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Review of viral testing (polymerase chain reaction) and antibody/serology testing for severe acute respiratory syndrome-coronavirus-2 for the intensivist

For the San Matteo Pavia COVID-19 Task Force. Detection of the SARS-CoV-2 in different biologic specimens from positive patients with COVID-19, in Northern Italy

Upper respiratory tract sampling in COVID-19

Laboratory diagnosis of emerging human coronavirus infections -the state of the art

Infectious Diseases Society of America Guidelines on the diagnosis of COVID-19

The Appropriate use of testing for COVID-19

Detection of SARS-CoV-2 in different types of clinical specimens

Occurrence and timing of subsequent severe acute respiratory syndrome coronavirus 2 reverse-transcription polymerase chain reaction positivity among initially negative patients

Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS CoV-2 tests by time since exposure

Laryngotracheal aspiration test reduce the false negative rate in patients with suspected SARS-COV-2 pneumonia despite a negative nasopharyngeal swab

Analysis of sputum/tracheal aspirate and nasopharyngeal samples for SARS-CoV-2 detection by laboratory-developed test and Panther Fusion system

Nasal swab versus nasopharyngeal aspirate for isolation of respiratory viruses

Comparative study of nasopharyngeal aspirate and nasal swab specimens for diagnosis of acute viral respiratory infection

The authors declare that there are no conflicts of interest.

https://orcid.org/0000-0001-7108-9194